Millner F. Ann Ed.D.

SEC source: 0001649014-26-000002 · form4-05192026_100524.xml · nonDerivative · entry 1

Millner F. Ann Ed.D. · CIK 0001649014 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 38,000

F1 · shares: The reported transaction involved the reporting person's receipt of a grant of 3,457 restricted stock units (RSUs) under the Merit Medical Systems, Inc. 2026 Equity Incentive Plan. The RSUs granted to the reporting person will vest on May 3, 2027. Vesting of the RSUs is subject to continued service to the issuer through the vesting date.

SEC source: 0001415889-25-013726 · form4-05192025_100531.xml · derivative · entry 5

Millner F. Ann · CIK 0001649014 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 7,500 shares

Expires 2026-05-31

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · kind: The acquisition of shares pursuant to an outstanding option and sale of those shares were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan adopted on August 7, 2023.

F5 · derivative.exercise_date: Becomes exercisable in equal annual installments of 33% commencing 05/31/2020.

SEC source: 0001415889-25-013726 · form4-05192025_100531.xml · derivative · entry 4

Millner F. Ann · CIK 0001649014 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 13,750 shares

Expires 2026-05-24

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · kind: The acquisition of shares pursuant to an outstanding option and sale of those shares were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan adopted on August 7, 2023.

F4 · derivative.exercise_date: Becomes exercisable in equal annual installments of 33% commencing 05/24/2020.

SEC source: 0001415889-25-013726 · form4-05192025_100531.xml · nonDerivative · entry 3

Millner F. Ann · CIK 0001649014 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 34,543

F2 · kind: The acquisition of shares pursuant to an outstanding option and sale of those shares were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan adopted on August 7, 2023.

F3 · price: The price reported in Column 4 of Table 1 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $96.16 to $97.16, inclusive. The Reporting Person undertakes to provide to Merit Medical Systems, Inc., any security holder of Merit Medical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

SEC source: 0001415889-25-013726 · form4-05192025_100531.xml · nonDerivative · entry 2

Millner F. Ann · CIK 0001649014 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 55,793

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · kind: The acquisition of shares pursuant to an outstanding option and sale of those shares were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan adopted on August 7, 2023.

SEC source: 0001415889-25-013726 · form4-05192025_100531.xml · nonDerivative · entry 1

Millner F. Ann · CIK 0001649014 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 34,543

F1 · shares: The reported transaction involved the reporting person's receipt of a grant of 2,152 restricted stock units (RSUs) under the Merit Medical Systems, Inc. 2018 Long-Term Incentive Plan. The RSUs vest on May 15, 2026. Vesting of the RSUs is subject to continued service to the issuer through the vesting date.

SEC source: 0001415889-24-027066 · form4-11182024_081155.xml · derivative · entry 3

Millner F. Ann · CIK 0001649014 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 12,500 shares

Expires 2025-06-07

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 7, 2023.

F3 · derivative.exercise_date: Becomes exercisable in equal annual installments of 20% commencing 06/07/2019.

SEC source: 0001415889-24-027066 · form4-11182024_081155.xml · nonDerivative · entry 2

Millner F. Ann · CIK 0001649014 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 32,391

F1 · kind: The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 7, 2023.

F2 · price: The price reported in Column 4 of Table 1 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $100.78 to $101.97, inclusive. The Reporting Person undertakes to provide to Merit Medical Systems, Inc., any security holder of Merit Medical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

SEC source: 0001415889-24-027066 · form4-11182024_081155.xml · nonDerivative · entry 1

Millner F. Ann · CIK 0001649014 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 44,891

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 7, 2023.

SEC source: 0001415889-24-018740 · form4-07022024_020720.xml · derivative · entry 4

Millner F. Ann · CIK 0001649014 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,500

Underlying: Common Stock · 12,500 shares

Expires 2025-06-07

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 7, 2023.

F2 · derivative.exercise_date: Becomes exercisable in equal annual installments of 20% commencing 06/07/2019.

SEC source: 0001415889-24-018740 · form4-07022024_020720.xml · nonDerivative · entry 3

Millner F. Ann · CIK 0001649014 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 32,391

F1 · kind: The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 7, 2023.

SEC source: 0001415889-24-018740 · form4-07022024_020720.xml · nonDerivative · entry 2

Millner F. Ann · CIK 0001649014 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 32,592

F1 · kind: The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 7, 2023.

SEC source: 0001415889-24-018740 · form4-07022024_020720.xml · nonDerivative · entry 1

Millner F. Ann · CIK 0001649014 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 44,891

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 7, 2023.

SEC source: 0001415889-24-013811 · form4-05202024_090534.xml · nonDerivative · entry 1

Millner F. Ann · CIK 0001649014 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 32,391

F1 · shares: The reported transaction involved the reporting person's receipt of a grant of 2,431 restricted stock units (RSUs) under the Merit Medical Systems, Inc. 2018 Long-Term Incentive Plan. The RSUs vest on May 16, 2025. Vesting of the RSUs is subject to continued service to the issuer through the vesting date.

SEC source: 0001415889-24-001732 · form4-01242024_030158.xml · derivative · entry 3

Millner F. Ann · CIK 0001649014 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 20,000 shares

Expires 2024-05-24

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The acquisition of shares pursuant to an outstanding option and sale of those shares were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan adopted on August 7, 2023.

F3 · derivative.exercise_date: Becomes exercisable in equal annual installments of 20% commencing 05/24/2018.

SEC source: 0001415889-24-001732 · form4-01242024_030158.xml · nonDerivative · entry 2

Millner F. Ann · CIK 0001649014 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 29,960

F1 · kind: The acquisition of shares pursuant to an outstanding option and sale of those shares were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan adopted on August 7, 2023.

F2 · price: The price reported in Column 4 of Table 1 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $80.000 to $80.035, inclusive. The Reporting Person undertakes to provide to Merit Medical Systems, Inc., any security holder of Merit Medical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

SEC source: 0001415889-24-001732 · form4-01242024_030158.xml · nonDerivative · entry 1

Millner F. Ann · CIK 0001649014 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 49,960

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The acquisition of shares pursuant to an outstanding option and sale of those shares were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan adopted on August 7, 2023.

SEC source: 0001415889-23-008479 · form4-05222023_060517.xml · nonDerivative · entry 1

Millner F. Ann · CIK 0001649014 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 29,960

F1 · shares: The reported transaction involved the reporting person's receipt of a grant of 2,262 restricted stock units (RSUs) under the Merit Medical Systems, Inc. 2018 Long-Term Incentive Plan. The RSUs vest on May 18, 2024. Vesting of the RSUs is subject to continued service to the issuer through the vesting date.

SEC source: 0001415889-22-006232 · form4-06072022_040630.xml · derivative · entry 3

Millner F. Ann · CIK 0001649014 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 10,000 shares

Expires 2023-05-26

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: Becomes exercisable in equal annual installments of 20% commencing 05/26/2017.

SEC source: 0001415889-22-006232 · form4-06072022_040630.xml · nonDerivative · entry 2

Millner F. Ann · CIK 0001649014 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 27,698

F1 · price: The price reported in Column 4 of Table 1 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $61.900 to $61.985, inclusive. The Reporting Person undertakes to provide to Merit Medical Systems, Inc., any security holder of Merit Medical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

SEC source: 0001415889-22-006232 · form4-06072022_040630.xml · nonDerivative · entry 1

Millner F. Ann · CIK 0001649014 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 34,076

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001415889-22-005728 · form4-05262022_030529.xml · nonDerivative · entry 1

Millner F. Ann · CIK 0001649014 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,076

F1 · shares: The reported transaction involved the reporting person's receipt of a grant of 3,050 restricted stock units (RSUs) under the Merit Medical Systems, Inc. 2018 Long-Term Incentive Plan. The RSUs vest on May 24, 2023. Vesting of the RSUs is subject to continued service to the issuer through the vesting date.

SEC source: 0001415889-21-003132 · form4-06212021_040647.xml · nonDerivative · entry 1

Millner F. Ann · CIK 0001649014 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,026

F1 · balance_after: The reported transaction involved the reporting person's receipt of a grant of 2,914 restricted stock units under the Merit Medical System, Inc. 2018 Long-Term Incentive Plan. The reporting person has reported prior awards of restricted stock units in Table II of Form 4. The total reported in Column 5 of Table I includes the 2,914 newly awarded restricted stock units that vest on June 17, 2022, 4,188 previously reported time-vesting restricted stock units that vest on June 22, 2021, and 13,924 shares of common stock. Vesting of restricted stock units is subject to continued service to the issuer through the vesting date.

SEC source: 0001415889-21-001555 · form4-03172021_030342.xml · derivative · entry 3

Millner F. Ann · CIK 0001649014 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 4,246 shares

Expires 2022-07-16

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: In the Reporting Person's Form 4 filed on June 24, 2020, the number of these options was incorrectly listed at 4,264 when the correct number of options was 4,246.

F2 · derivative.exercise_date: Becomes exercisable in equal annual installments of 20% commencing 07/16/2016.

F1 · derivative.underlying_shares: In the Reporting Person's Form 4 filed on June 24, 2020, the number of these options was incorrectly listed at 4,264 when the correct number of options was 4,246.

SEC source: 0001415889-21-001555 · form4-03172021_030342.xml · nonDerivative · entry 2

Millner F. Ann · CIK 0001649014 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,924

SEC source: 0001415889-21-001555 · form4-03172021_030342.xml · nonDerivative · entry 1

Millner F. Ann · CIK 0001649014 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,476

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001415889-20-001701 · form4-06242020_050624.xml · derivative · entry 2

Millner F. Ann · CIK 0001649014 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,188

Underlying: Common Stock · 4,188 shares

Expires 2021-06-22

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock upon vesting.

F2 · derivative.exercise_date: Each restricted stock unit vests on June 22, 2021 subject to continued service to the Issuer through the vesting date.

SEC source: 0000856982-19-000115 · wf-form4_156625579583030.xml · derivative · entry 6

Millner F. Ann · CIK 0001649014 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,000

Underlying: Common Stock · 5,000 shares

Expires 2023-05-26

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: Becomes exercisable in equal annual installments of 20% commencing 05/26/2017.

SEC source: 0000856982-19-000115 · wf-form4_156625579583030.xml · derivative · entry 5

Millner F. Ann · CIK 0001649014 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,246

Underlying: Common Stock · 4,246 shares

Expires 2022-07-16

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: Becomes exercisable in equal annual installments of 20% commencing 07/16/2016.

SEC source: 0000856982-19-000115 · wf-form4_156625579583030.xml · nonDerivative · entry 4

Millner F. Ann · CIK 0001649014 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,230

F2 · price: Stock options were exercised in a swap transaction with the Company. 2,534 shares of common stock were surrendered for payroll taxes and payment of the option price. None of such shares were sold in the open market.

SEC source: 0000856982-19-000115 · wf-form4_156625579583030.xml · nonDerivative · entry 3

Millner F. Ann · CIK 0001649014 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,764

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0000856982-19-000115 · wf-form4_156625579583030.xml · nonDerivative · entry 2

Millner F. Ann · CIK 0001649014 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,518

F1 · price: The price reported in Column 4 of Table 1 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.67 to $36.69, inclusive. The Reporting Person undertakes to provide to Merit Medical Systems, Inc., any security holder of Merit Medical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

SEC source: 0000856982-19-000115 · wf-form4_156625579583030.xml · nonDerivative · entry 1

Millner F. Ann · CIK 0001649014 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,298

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0000856982-19-000083 · wf-form4_155968049842499.xml · derivative · entry 7

Millner F. Ann · CIK 0001649014 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,500

Underlying: Common Stock · 7,500 shares

Expires 2026-05-31

F6 · derivative.exercise_date: Becomes exercisable in equal annual installments of 33% commencing 05/31/2020.

SEC source: 0000856982-19-000065 · wf-form4_155917115138478.xml · derivative · entry 6

Millner F. Ann · CIK 0001649014 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,750

Underlying: Common Stock · 13,750 shares

Expires 2026-05-24

F5 · derivative.exercise_date: Becomes exercisable in equal annual installments of 33% commencing 05/24/2020.

SEC source: 0000856982-18-000074 · wf-form4_154119460030376.xml · derivative · entry 7

Millner F. Ann · CIK 0001649014 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,000

Underlying: Common Stock · 5,000 shares

Expires 2024-05-24

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: Becomes exercisable in equal annual installments of 20% commencing 5/24/2018.

SEC source: 0000856982-18-000074 · wf-form4_154119460030376.xml · derivative · entry 6

Millner F. Ann · CIK 0001649014 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,000

Underlying: Common Stock · 5,000 shares

Expires 2023-05-26

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: Becomes exercisable in equal annual installments of 20% commencing 5/26/2017.

SEC source: 0000856982-18-000074 · wf-form4_154119460030376.xml · derivative · entry 5

Millner F. Ann · CIK 0001649014 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,492

Underlying: Common Stock · 4,247 shares

Expires 2022-07-16

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: Becomes exercisable in equal annual installments of 20% commencing 7/16/2016.

SEC source: 0000856982-18-000074 · wf-form4_154119460030376.xml · nonDerivative · entry 4

Millner F. Ann · CIK 0001649014 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,298

F1 · price: The price reported in Column 4 of Table 1 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $56.88 to $57.04, inclusive. The Reporting Person undertakes to provide to Merit Medical Systems, Inc., any security holder of Merit Medical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

SEC source: 0000856982-18-000074 · wf-form4_154119460030376.xml · nonDerivative · entry 3

Millner F. Ann · CIK 0001649014 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,891

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0000856982-18-000074 · wf-form4_154119460030376.xml · nonDerivative · entry 2

Millner F. Ann · CIK 0001649014 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,891

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0000856982-18-000074 · wf-form4_154119460030376.xml · nonDerivative · entry 1

Millner F. Ann · CIK 0001649014 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,891

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0000856982-18-000048 · wf-form4_152875435537820.xml · derivative · entry 5

Millner F. Ann · CIK 0001649014 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,000

Underlying: Common Stock · 25,000 shares

Expires 2025-06-07

F4 · derivative.exercise_date: Becomes exercisable in equal annual installments of 20% commencing 06/07/2019.

SEC source: 0001179110-17-011190 · edgar.xml · derivative · entry 3

Millner F. Ann · CIK 0001649014 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,739

Underlying: Common Stock · 4,247 shares

Expires 2022-07-16

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: Becomes exercisable in equal annual installments of 20% commencing 7/16/2016.

SEC source: 0001179110-17-011190 · edgar.xml · nonDerivative · entry 2

Millner F. Ann · CIK 0001649014 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,644

F1 · price: The price reported in Column 4 of Table 1 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.005 to 41.05, inclusive. The reporting person undertakes to provide to Merit Medical Systems, Inc., any security holder of Merit Medical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

SEC source: 0001179110-17-011190 · edgar.xml · nonDerivative · entry 1

Millner F. Ann · CIK 0001649014 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,750

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001179110-17-009778 · edgar.xml · derivative · entry 5

Millner F. Ann · CIK 0001649014 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,000

Underlying: Common Stock · 5,000 shares

Expires 2023-05-26

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: Becomes exercisable in equal annual installments of 20% commencing 5/26/2017.

SEC source: 0001179110-17-009778 · edgar.xml · derivative · entry 4

Millner F. Ann · CIK 0001649014 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,986

Underlying: Common Stock · 4,247 shares

Expires 2022-07-16

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: Becomes exercisable in equal annual installments of 20% commencing 7/16/2016.

SEC source: 0001179110-17-009778 · edgar.xml · nonDerivative · entry 3

Millner F. Ann · CIK 0001649014 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,503

F1 · price: The price reported in Column 4 of Table 1 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.00 to 38.33, inclusive. The reporting person undertakes to provide to Merit Medical Systems, Inc., any security holder of Merit Medical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

SEC source: 0001179110-17-009778 · edgar.xml · nonDerivative · entry 2

Millner F. Ann · CIK 0001649014 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,247

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.